Novel Droplet Microfluidic Assay on a Chip Platform For Immune Profiling in Cancer Immunotherapy
Northeastern spinout, Feromics, is developing ScanDrop to track single cells from assay to omics, with special uses in cancer immunotherapy
Published: 25th July 2022

IP Status
- Patented
Seeking
- Development partner
- Commercial partner
- University spin out
- Seeking investment